Drug Profile
RAS 111
Alternative Names: RAS-111Latest Information Update: 13 Oct 2009
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sepsis
Most Recent Events
- 13 Oct 2009 Discontinued - Phase-0 for Sepsis in USA (IV)